A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation

PHASE4CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

August 31, 2007

Conditions
Mechanically Ventilated and Intubated Subjects
Interventions
DRUG

Dexmedetomidine HCL Injection

DRUG

Midazolam Injection

Trial Locations (96)

2031

Randwick

2148

Blacktown

3050

Parkville

3084

Heidelberg

3128

Box Hill

4201

Hastings

5011

Woodville

5301

Palmerston North

6000

Perth

6002

Welling

7001

Hobart

8001

Christchurch

10011

New York

11215

Brooklyn

11501

Mineola

11794

Stoney Brook

13210

Syracuse

14215

Buffalo

14642

Rochester

15146

Monroeville

15219

Pittsburgh

17882

Danville

19718

Newark

20010

Washington D.C.

21201

Baltimore

24501

Lynchburg

26505

Morgantown

27599

Chapel Hill

28207

Charlotte

29303

Spartanburg

29425

Charleston

30905

Gordon

30909

Augusta

32804

Orlando

33606

Tampa

33744

Bay Pines

35294

Birmingham

38163

Memphis

41701

Hazard

44307

Akron

45429

Dayton

Kettering

48532

Flint

52242

Iowa City

53792

Madison

60005

Arlington Heights

60302

Oak Park

61603

Peoria

66061

Olathe

66160

Kansas City

68131

Omaha

71301

Alexandria

72756

Rogers

73104

Olkahoma City

77024

Houston

77555

Galveston

79430

Lubbock

80204

Denver

84403

Ogden

85248

Chandler

85258

Scottsdale

91105

Pasadena

92354

Loma Linda

92373

Redlands

92672

San Clemente

94304

Palo Alto

95616

Davis

95819

Sacramento

97504

Medford

Unknown

Phoenix

San Francisco

San Jose

Miami

Atlanta

Indianapolis

Louisville

Shreveport

Portland

Missoula

The Bronx

Greensboro

Winston-Salem

Toledo

Dallas

Ciudad de Buenos Aires

06030

Farmington

06520

New Haven

04005

Biddeford

02115

Boston

08103

Camden

07631

Englewood

90020-090

Porto Alegre

90610-000

Porto Alegre

04039-901

Pedro de Toledo

09190-610

Santo André

01323-001

São Paulo

All Listed Sponsors
lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00216190 - A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation | Biotech Hunter | Biotech Hunter